Merck Drops $9.2 Billion on Experimental Flu Drug — Could This Save Its Post-Keytruda Future?
Merck Stuns Wall Street With $9.2 Billion Bet In a jaw-dropping move,…
Novartis Drops $12 Billion Bombshell Deal That Could Shake the Pharma World
In a jaw-dropping move, Novartis announced it is acquiring U.S. biotech firm…